Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Healthcare
Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators... see more

Recent & Breaking News (TSX:QIPT)

IIROC Trading Resumption - PHM; PHM.DB

Canada NewsWire May 9, 2018

Protech Home Medical Announces Approval of Corporate Name Change

GlobeNewswire May 7, 2018

Patient Home Monitoring Announces Plans to Change Name to Protech Home Medical; Launches New Investor Website

GlobeNewswire April 10, 2018

Patient Home Monitoring Releases Quarterly Conference Call

GlobeNewswire March 15, 2018

Patient Home Monitoring Announces Date and Time for Quarterly Conference Call

GlobeNewswire March 8, 2018

Patient Home Monitoring Releases First Quarter Financial Results

GlobeNewswire March 2, 2018

PHM Announces Organic Growth Strategy; Acquisition (M&A) and Technology Investment Plans

MarketWire Canada January 29, 2018

PHM Announces Expansion & Results of Telemedicine Pilot Program; Provides Post-Spinoff Status

GlobeNewswire January 22, 2018

PHM Announces Further Details of Plan of Arrangement

GlobeNewswire January 19, 2018

PHM Provides Update on TSX-V Listing

MarketWire Canada December 22, 2017

PHM Provides Update on Spin-Out and Timing of Closing

MarketWire Canada December 20, 2017

Patient Home Monitoring Securityholders Vote in Favour of Plan of Arrangement with Viemed Healthcare

MarketWire Canada December 15, 2017

PHM Provides Update on Spin-Out and Meeting of Securityholders

MarketWire Canada November 20, 2017

Patient Home Monitoring Announces Update to Timing of Proposed Split into Separate Operating Companies and Expected Date for Shareholder Meeting

GlobeNewswire November 2, 2017

Patient Home Monitoring Releases Conference Call Highlighting Financial Q3 FY 2017

GlobeNewswire August 24, 2017

Patient Home Monitoring Releases Third Quarter Financials; Increases Cash Position and Posts Increase in Quarterly Revenues; Third Straight Quarter of Positive Adjusted EBITDA

GlobeNewswire August 23, 2017

Patient Home Monitoring Announces Date and Time for Quarterly Conference Call

GlobeNewswire August 7, 2017

FDA Chooses Zepsyre™ (PM1183) from PharmaMar to Explore Potential Development for Pediatric Cancers

PR Newswire June 20, 2017

PharmaMar Will Commercialize PM1183 With the Trade Name of Zepsyre™

PR Newswire June 16, 2017

PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers

PR Newswire Europe Non Regulatory June 13, 2017